Literature DB >> 18436073

The dangers of false-positive and false-negative test results: false-positive results as a function of pretest probability.

Brian R Jackson1.   

Abstract

This article focuses on the following key points of improving clinicians' use of laboratory tests: (1) laboratory tests are always imperfect, but some are much more imperfect than others; (2) limitations in human cognition compound the potential for misinterpretation of test results; (3) false-positive and false-negative laboratory results can lead to serious patient harm; and (4) judicious use of laboratory tests can help mitigate potential harm from spurious results.

Entities:  

Mesh:

Year:  2008        PMID: 18436073     DOI: 10.1016/j.cll.2007.12.009

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  9 in total

1.  Temporal artery biopsy in giant cell arteritis--reply.

Authors:  Lindsey B De Lott; James F Burke; Jonathan D Trobe
Journal:  JAMA Ophthalmol       Date:  2015-10       Impact factor: 7.389

2.  Appropriateness of tumor marker request: a case of study.

Authors:  Massimo Gion; Chiara Trevisiol; Aline S C Fabricio
Journal:  Ann Transl Med       Date:  2017-07

3.  Implications of the incidentalome for clinical pharmacogenomics.

Authors:  Kyle B Brothers; Martin Langanke; Pia Erdmann
Journal:  Pharmacogenomics       Date:  2013-08       Impact factor: 2.533

4.  New insights into the pathogenicity of non-synonymous variants through multi-level analysis.

Authors:  Hong Sun; Guangjun Yu
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

5.  Diagnosis accuracy of Raman spectroscopy in colorectal cancer: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Qiang Zheng; Weibiao Kang; Changyu Chen; Xinxin Shi; Yang Yang; Changjun Yu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.889

6.  Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence'.

Authors:  Tracy Merlin; Adele Weston; Rebecca Tooher
Journal:  BMC Med Res Methodol       Date:  2009-06-11       Impact factor: 4.615

7.  Advantages and limitations of anticipating laboratory test results from regression- and tree-based rules derived from electronic health-record data.

Authors:  Fahim Mohammad; Jesse C Theisen-Toupal; Ramy Arnaout
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

8.  ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens.

Authors:  Colin R Zamecnik; Jayant V Rajan; Kevin A Yamauchi; Sabrina A Mann; Rita P Loudermilk; Gavin M Sowa; Kelsey C Zorn; Bonny D Alvarenga; Christian Gaebler; Marina Caskey; Mars Stone; Philip J Norris; Wei Gu; Charles Y Chiu; Dianna Ng; James R Byrnes; Xin X Zhou; James A Wells; Davide F Robbiani; Michel C Nussenzweig; Joseph L DeRisi; Michael R Wilson
Journal:  Cell Rep Med       Date:  2020-09-24

9.  Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays.

Authors:  Elisabeth Kahre; Lukas Galow; Manja Unrath; Luise Haag; Judith Blankenburg; Alexander H Dalpke; Christian Lück; Reinhard Berner; Jakob P Armann
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.